What If LDRT Doesn't Work?

LDRT does not help everyone. Roughly 3 in 10 patients do not respond to the first course, in the estimate of radiation oncologist Dr. James Yu of Dartmouth^[1]. Before concluding it failed, though, timing matters: relief can keep developing after the last session. In a German analysis of 295 treated joints, pain scores kept falling between the end of treatment and the first follow-up visit, and the benefit held for at least 24 months^[2]. Judging too early is the most common mistake.

When to Judge the First Course

Give it time. The American Radium Society guideline suggests reassessing at 6 to 12 weeks after the first course^[3]. US reviewers recommend waiting at least 3 months to assess the full effect before considering anything further^[4]. The 2025 Korean sham-controlled knee trial measured its primary result at 4 months^[5]. If your pain is unchanged at the 3-month mark, that is the point to talk with your treatment team about next steps.

What the Guidelines Say About a Second Course

A second course is not a consolation prize. It is guideline-supported care. The American Radium Society states: "In patients who undergo a first course of RT with limited or no treatment response, a second course of treatment should be considered at 8 to 12 weeks either with same dose and fractionation scheme or a modified dose and fractionation scheme"^[3]. For minimal or no response at 6 to 12 weeks, the panel calls a second phase "recommended" and "standard of care," noting studies showing reirradiation is safe and effective, with total response rates above 80 percent^[3].

German practice agrees. The DEGRO benign-disease guideline states that if the effect is not sufficient, a second series at the same dosage can be given after 6 to 8 weeks^[6]. In published cohorts, retreatment is common: one Swiss prospective study built a second course, 8 weeks after the first, into its protocol for anyone without complete pain relief^[7], and another retreated 21 percent for no response, 42 percent for partial response, and 37 percent for recurrent pain^[4]. US reviewers generally use the same dose for retreatment (0.5 Gy twice weekly, 3 Gy total) and usually do not treat a joint more than twice^[4].

What About a Third Course?

For recurrent symptoms after two courses, the American Radium Society says a third course can be considered, ideally reserved for patients with limited alternative options, who responded to earlier treatment, and whose first durable response lasted at least a year^[3]. The panel is candid that additional courses are generally thought to be less effective than the first, especially without a robust initial response, and that the secondary-malignancy discussion must happen before proceeding^[3]. There is no well-defined lifetime dose limit for retreatment; decisions are individualized^[3].

If LDRT Still Does Not Help

One reassurance first: "no data have been published to show LDRT increases surgical risks or prohibit patients from undergoing surgical interventions after LDRT"^[3]. Trying LDRT does not close the surgery door. The standard options remain: corticosteroid injections, hyaluronic acid injections, or surgery for medically refractory arthritis^[4]. No guideline prescribes a fixed sequence after failed LDRT. The American Radium Society leaves it to shared decision-making: a full discussion of risks, benefits, and alternatives between physician and patient^[3].

References:
1. 1 course of radiotherapy may relieve osteoarthritis pain. Medical News Today, quoting Dr. James Yu (Dartmouth). Article
2. Hautmann MG, et al. Radiotherapy for osteoarthritis, an analysis of 295 joints treated with a linear accelerator. Strahlentherapie und Onkologie. 2020;196:715-724. Journal page
3. American Radium Society Appropriate Use Criteria for Use of Radiotherapy for Treatment of Osteoarthritis. Expert Panel for Use of Radiotherapy in the Treatment of Arthritis. 2026. Full guideline document (Subtopics 4 and 5; Summary Recommendations 8 and 9; Topic 2). Full document (PDF)
4. Yu JB, et al. Low-Dose Radiation Therapy for Osteoarthritis: A Review. Practical Radiation Oncology. 2025;15:19-24. Review (PDF)
5. Low-dose radiation improved knee osteoarthritis pain. Medscape, on the 2025 Korean sham-controlled trial (ASTRO). Article
6. German Society for Radiation Oncology (DEGRO). S2e Guideline: Radiation Therapy of Benign Diseases, Version 3.0. Guideline (PDF)
7. Rogers S, et al. Prospective Evaluation of Changes in Pain Levels, Quality of Life and Functionality After Low Dose Radiotherapy for Epicondylitis, Plantar Fasciitis, and Finger Osteoarthritis. Frontiers in Medicine. 2020;7:195. Full text